Hallucinogen dependence
- F16.2 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2025 edition of ICD-10-CM F16.2 became effective on October 1, 2024.
- This is the American ICD-10-CM version of F16.2 – other international versions of ICD-10 F16.2 may differ.
Type 1 Excludes
- hallucinogen abuse (F16.1-)
- hallucinogen use, unspecified (F16.9-)
The following code(s) above F16.2 contain annotation back-references
that may be applicable to F16.2:
Clinical Information
- A drug dependence for a hallucinogenic substance.
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
Code annotations containing back-references to F16.2:
- Type 1 Excludes: F16.1, F16.9